Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -111.71M | -114.04M | -51.99M | -54.65M | -52.35M |
| Total Depreciation and Amortization | 231.00K | 225.00K | 223.00K | 228.00K | 229.00K |
| Total Amortization of Deferred Charges | 50.00K | 48.00K | 50.00K | 52.00K | 55.00K |
| Total Other Non-Cash Items | 64.12M | 66.74M | 5.88M | 9.17M | 9.45M |
| Change in Net Operating Assets | 3.26M | 7.00K | 531.00K | -4.27M | 1.94M |
| Cash from Operations | -44.04M | -47.02M | -45.31M | -49.47M | -40.68M |
| Capital Expenditure | -52.00K | -19.00K | -3.00K | -3.00K | -- |
| Sale of Property, Plant, and Equipment | 4.00K | 4.00K | 4.00K | 4.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.43M | -135.46M | 9.03M | 6.11M | 17.12M |
| Cash from Investing | -124.48M | -135.47M | 9.03M | 6.11M | 17.12M |
| Total Debt Issued | 5.00M | 5.00M | 5.00M | 5.00M | 0.00 |
| Total Debt Repaid | -1.88M | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 193.20M | 173.78M | 46.55M | 46.53M | 45.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 196.32M | 178.78M | 51.55M | 51.53M | 45.95M |
| Foreign Exchange rate Adjustments | 3.00K | 5.00K | 4.00K | 3.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.81M | -3.70M | 15.28M | 8.18M | 22.39M |